The role of DAPK in the tumorigenesis of gastrointestinal cancer remains unknown, but in malignant lymphoma, loss of DAPK reduces responsiveness to interferon-γ (Katzenellenbogen et al, 1999). This evidence concerns the gene DAPK1 and lymphoma.